The Press and Journal (Inverness, Highlands, and Islands)
Charity hopes last report will offer nd clarity on scandal
The final report of the Infected Blood Inquiry will hopefully reveal who thought that the haemophilia community was “expendable” when they were given a contaminated blood product, a charity has said.
A “horrifying” number of people with haemophilia suffered harm as a result of the infected blood scandal, the Haemophilia Society said.
It comes as pressure mounts ahead of publication of the inquiry’s final report on May 20.
Kate Burt, chief executive of the Haemophilia Society, said that people in the haemophilia community hope the “truth will finally come out” when the report is published.
She described the publication of the report as a “significant milestone” for people with the blood disorder, but said that for many the scandal “will never end”.
About 4,900 people with haemophilia were infected,
almost all with hepatitis, but 2,500 of these were coinfected with hepatitis and HIV.
Of the group who were infected with Hepatitis C and HIV, about 250 are still alive today.
“Statistically, the numbers are horrifying,” Ms Burt said.
“The long-term psychological impact of this has been disastrous for people.
“Another horrendous thing is those, the surviving infected, are waiting for the comorbidities to hit them, whether it’s, you know, liver cancer or, you know, something else happening.
“Every story you hear has just the multiple layers of loss – the loss of the ability to have children, the loss of careers, having to give up careers to be carers, not getting married... just every normal stage of life was derailed.”
Haemophilia is an inherited disorder where the blood does not clot properly. Most people with the condition have a shortage of the protein that enables human blood to clot, known as Factor VIII.
In the 1970s, a new treatment was developed to replace the missing clotting agent, which was made from donated human blood plasma.
Manufacturers made the product by pooling plasma from tens of thousands of people – increasing the risk of the product containing blood infected with viruses including hepatitis and HIV.
Many patients welcomed this new treatment, which could be delivered by injection at home, as prior to its introduction patients required transfusions with plasma which had to be given in hospital.
“The plasma pooling meant that it was inherently unsafe,” Ms Burt said.
“There only needed one person with a virus to contaminate that whole pool of product, but they did it anyway.
“And we know from the research done in the States that they targeted prisons (for donations) – they targeted Arkansas, they targeted Louisiana. They asked people to sell their blood to them.
“The risks that they were minimising proved to be catastrophic.
“So this miracle treatment, which was supposed to transform the lives of people with haemophilia – and it did – also killed them.”
On the publication of the report, she said: “I think it’s a significant milestone. This is a story that will never end for you know, it’s a multi-generational scandal.”